Sort
48,018 grants matching “immunotherapy”
SOUTHWEST ONCOLOGY GROUP
$468,138Swedish Medical Center, First Hill · U10 · FY2003 · CA
Posttranscriptional control of gene expression
$468,099Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Novel therapeutic approaches with CDK4/6 inhibitors for melanoma treatment
$468,091Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Novel therapeutic approaches with CDK4/6 inhibitors for melanoma treatment
$468,091Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Enhancing neoadjuvant chemotherpay responses with targeted T cells
$468,081Lawrence G Lum · Wayne State University · R01 · FY2013 · CA
Targeting immune inhibitory molecule SUSD2 to reverse immunosuppression
$468,070Haitao Wen · Ohio State University · R01 · FY2021 · AI
Cell and Gene Therapy, Clinical Manufacture and Monitoring Core
$468,055Antoni Ribas · California Institute Of Technology · P01 · FY2011 · CA
Targeting the innate immune response in HNSCC
$468,023Judith A. Varner · University Of California, San Diego · R01 · FY2017 · DE
Modulation of repopulation of anti HIV-1 gene-modified cells to enhance efficacy and safety
$468,000Dong Sung An · University Of California Los Angeles · U19 · FY2020 · AI
Enhancing HSPC CAR-mediated immunity in vivo
$468,000Scott G Kitchen · University Of California Los Angeles · U19 · FY2020 · AI
Immunologic basis of phenotypic heterogeneity in peanut allergy
$467,975Maria Cecilia Berin · Icahn School Of Medicine At Mount Sinai · U19 · FY2021 · AI
Multiscale Computational Models Guided By Emerging Cellular Dynamics Quantification For Predicting Optimum Immune Checkpoint And Targeted Therapy Schedules
$467,951Trachette Jackson · University Of Michigan At Ann Arbor · U01 · FY2024 · CA
Cellular Transduction with Replication-Competent Retrovirus Vectors
$467,899Noriyuki Kasahara · University Of California Los Angeles · R01 · FY2008 · CA
Microbiome Function in Atopic Dermatitis
$467,791Richard L Gallo · University Of California, San Diego · U01 · FY2025 · AI
Combination of Anti-CD3 and Ag-Specific Immunotherapy
$467,750Columbia University Health Sciences · R21 · FY2004 · DK
Transport of Effector T cells and Nano-DC vaccine in Breast Cancer
$467,748Elizabeth Mittendorf · Methodist Hospital Research Institute · U54 · FY2018 · CA
Modulation of Tolerance and Autoimmunity by Inhibitory Receptors
$467,689Arlene H Sharpe · University Of Pittsburgh At Pittsburgh · P01 · FY2017 · AI
Cell and Gene Therapy, Clinical Manufacture and Monitoring Core
$467,624Antoni Ribas · California Institute Of Technology · P01 · FY2012 · CA
Mechanisms of STING in malignant progression and therapy of CLL.
$467,536Chih-Chi Andrew Hu · Methodist Hospital Research Institute · R01 · FY2024 · CA
Deciphering the Roles of STING-Mediated T cell Pyroptosis in Antitumor Immunity
$467,502Jianjun Wu · Cleveland Clinic Lerner Com-Cwru · R37 · FY2025 · CA
Deciphering the Roles of STING-Mediated T cell Pyroptosis in Antitumor Immunity
$467,502Jianjun Wu · Cleveland Clinic Lerner Com-Cwru · R37 · FY2024 · CA
Chemotherapy plus vaccine for metastatic breast cancer
$467,494Johns Hopkins University · R01 · FY2002 · CA
Head & Neck Cancer Neoantigen Characterization & Therapeutic Targeting
$467,480Young J. Kim · Vanderbilt University Medical Center · R01 · FY2019 · DE
Specific Adoptive Immunotherapy of Myeloid Malignancy
$467,429Philip D Greenberg · Fred Hutchinson Cancer Research Center · P01 · FY2015 · CA
Specific Adoptive Immunotherapy of Myeloid Malignancy
$467,429Philip D Greenberg · Fred Hutchinson Cancer Research Center · P01 · FY2016 · CA